Evolution Briefing: COVID 19 Vaccine UpdateJuly 24, 2020
Evolution Briefing: Avacta Group announce new CDOAugust 17, 2020
Since the virus first emerged in January, around 170 vaccine candidates
are now in development, with 29 already in human trials. This briefing
aims to highlight selected COVID-19 vaccine candidates currently in
Phase I-III trials, as well as major candidates in pre-clinical stages of
development and research.